NCT05504798

Brief Summary

Combining the advantages of both Neuromuscular electrical stimulation and lower limb serial casting to a selected physical therapy program in children with spastic diplegic cerebral palsy to overcome the adverse effects during the period of casting and the long period of rehabilitative interventions, providing a new multimodal treatment approach.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
60

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Aug 2022

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

August 1, 2022

Completed
11 days until next milestone

First Submitted

Initial submission to the registry

August 12, 2022

Completed
5 days until next milestone

First Posted

Study publicly available on registry

August 17, 2022

Completed
8 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 1, 2023

Completed
4 months until next milestone

Study Completion

Last participant's last visit for all outcomes

August 1, 2023

Completed
Last Updated

February 8, 2023

Status Verified

August 1, 2022

Enrollment Period

8 months

First QC Date

August 12, 2022

Last Update Submit

February 6, 2023

Conditions

Keywords

Diplegia, Neuromuscular electrical stimulation, Casting.

Outcome Measures

Primary Outcomes (3)

  • Change of knee and ankle passive range of motion (ROM)

    Digital Goniometer will be used to measure the passive ROM of ankle dorsiflexion and the popliteal angle (PA)

    At the beginning and after six weeks of intervention

  • Change of strength of knee extensors and ankle dorsiflexors muscles

    Hand-held dynamometers (HHDs) " Lafayette manual muscle tester" (MMT) Will be used for quantitative assessment of maximal voluntary isometric contraction for knee extensors, and ankle dorsiflexors.

    At the beginning and after six weeks of intervention

  • Change of tone of hamstring and gastrocnemius muscles

    The Modified Tardieu Scale (MTS) will be used for analysis of dynamic spasticity of gastrocnemius and hamstring muscles. Measuring R1 (the fast velocity movement of the ankle or knee through the full ROM to determine the point of catch in the ROM), R2 (the passive ROM), and R2-R1 (dynamic component of spasticity).

    At the beginning and after six weeks of intervention

Secondary Outcomes (1)

  • Change in sagittal kinematics parameters of gait pattern

    At the beginning and after six weeks of intervention

Study Arms (3)

Group (A)

ACTIVE COMPARATOR

will receive a selected physical therapy program.

Other: Selected physical therapy program

Group (B)

ACTIVE COMPARATOR

will receive interrupted progressive serial casting in addition to a modified selected physical therapy program during casting.

Other: Selected physical therapy programProcedure: Interrupted serial casting

Group (C)

ACTIVE COMPARATOR

will receive interrupted progressive serial casting and the modified selected physical therapy as group (B) in addition to neuromuscular electrical stimulation for ankle dorsiflexors and knee extensors muscles through cast windows

Other: Selected physical therapy programProcedure: Interrupted serial castingDevice: Neuromuscular electrical stimulation

Interventions

Selected physical therapy program one hour three times weekly for six successive weeks including stretching, strengthening, balance, and gait training.

Group (A)Group (B)Group (C)

Interrupted casting for 5 days a week for six successive weeks using a dual cast which consists of a standard short leg cast and a circular cast from below the knee to above the knee.

Group (B)Group (C)

Neuromuscular electrical stimulation in form of faradic current with frequency of 50 Hz, and intensity of maximum tolerable intensity to produce a visible contraction but as tolerated by the child for ankle dorsiflexors and knee extensors muscles through cast windows over the motor points of these muscles for 30 min 3 times weekly for six successive weeks

Group (C)

Eligibility Criteria

Age3 Years - 7 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)

You may qualify if:

  • The children will have grade 2 or 3 on Modified Ashworth Scale.
  • The children will have Level II, or III according to the Gross Motor Function Classification System.
  • The children walk with equinus or jump gait patterns with spasticity of the hamstrings and hip flexors in addition to calf muscles spasticity.
  • Children take their Antispastic drug use such as baclofen, diazepam or tizanidine.
  • All children will be able to follow instructions.

You may not qualify if:

  • children will be excluded from the study if they have any problems of the following:
  • Cognitive dysfunction.
  • Poor skin integrity.
  • History of or recent nonunion fracture.
  • Fixed contractures and deformities.
  • Previous surgery (tendon lengthening).
  • Received Botulinum toxin A injections in the last six months.
  • Impaired circulation.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Faculty of Physical Therapy

Cairo, Egypt

RECRUITING

MeSH Terms

Conditions

Cerebral Palsy

Condition Hierarchy (Ancestors)

Brain Damage, ChronicBrain DiseasesCentral Nervous System DiseasesNervous System Diseases

Central Study Contacts

Yasser M Abd Elmonem, MSC

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
FACTORIAL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal investigator

Study Record Dates

First Submitted

August 12, 2022

First Posted

August 17, 2022

Study Start

August 1, 2022

Primary Completion

April 1, 2023

Study Completion

August 1, 2023

Last Updated

February 8, 2023

Record last verified: 2022-08

Data Sharing

IPD Sharing
Will not share

Locations